Studies have shown that Cervarix is highly effective in preventing infections with HPV types 16 and 18. It has demonstrated up to 100% efficacy in preventing CIN2+ (cervical intraepithelial neoplasia grade 2 or worse) caused by these HPV types in women who were not previously exposed to these viruses.
